Organogenesis (Dec 2023)

Human Hepatocellular response in Cholestatic Liver Diseases

  • Kimberly Ortiz,
  • Zeliha Cetin,
  • Yiyue Sun,
  • Zhiping Hu,
  • Takeshi Kurihara,
  • Edgar N. Tafaleng,
  • Rodrigo M. Florentino,
  • Alina Ostrowska,
  • Alejandro Soto-Gutierrez,
  • Lanuza A.P. Faccioli

DOI
https://doi.org/10.1080/15476278.2023.2247576
Journal volume & issue
Vol. 19, no. 1

Abstract

Read online

ABSTRACTPrimary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), the most common types of cholestatic liver disease (CLD), result in enterohepatic obstruction, bile acid accumulation, and hepatotoxicity. The mechanisms by which hepatocytes respond to and cope with CLD remain largely unexplored. This study includes the characterization of hepatocytes isolated from explanted livers of patients with PBC and PSC. We examined the expression of hepatocyte-specific genes, intracellular bile acid (BA) levels, and oxidative stress in primary-human-hepatocytes (PHHs) isolated from explanted livers of patients with PBC and PSC and compared them with control normal human hepatocytes. Our findings provide valuable initial insights into the hepatocellular response to cholestasis in CLD and help support the use of PHHs as an experimental tool for these diseases.

Keywords